FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Feb 26, 2019
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on February 26, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d4274806-8b3e-49c5-b97b-36dcc2829714
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081205
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.5(d)CPR certification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2024 | Not classified | Florida District Office | |
| February 9, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 14, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1250131 - 2024-09-24
- FDA Inspection 1162423 - 2022-02-09
- FDA Inspection 997062 - 2016-12-14
- FDA Inspection 913508 - 2015-02-11
- FDA Inspection 827219 - 2013-04-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.